Have you taken testosterone replacement therapies AndroGel, Axiron, Testim or AndroDerm and suffered a heart attack, stroke or pulmonary embolism? If you have, you may have a claim that your cardiovascular event was the result of this testosterone therapy. Our testosterone replacement therapy attorneys are well-equipped to answer your questions and provide the legal guidance you need.
Two new studies show a link between testosterone replacement therapies and heart attack and/or stroke. In November 2013, a study published in the Journal of the American Medical Association showed that testosterone replacement therapies are linked to an increased risk of heart attack, stroke or death in older men with pre-existing heart conditions. In January 2013, another study published in PLOSOne, another medical journal, found that low testosterone treatments may double the risk of heart attack in younger men with pre-existing heart conditions and in older men with no pre-existing heart conditions.
With an office in Williamsport, our lawyers are prepared to represent clients throughout Pennsylvania.
On January 31, 2014, the FDA announced it is investigating the safety of testosterone therapies in response to these new studies, including the potential for heart attack, stroke or even death.
In recent years, testosterone therapies including AndroGel have increased sales by more than a factor of five, generating more than $1.9 billion in sales in 2012.
If you or someone you loved took Androgel, Axiron, AndroDerm or Testim and suffered a heart attack, stroke, or pulmonary embolism, contact Cliff Rieders, Esq. Of the Rieders Travis Firm to determine if you have a claim. Lawsuits are presently being filed in federal U.S. District Court for the Northern District of Illinois and other federal courts.